Search research articles
Contact Us
Filters
Showing results (91-100 of 281) with videos related to
Page
of 29
Sort By:
Journal of Molecular Structure
|
December 5, 2022
Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences
Suvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, et al.
Journal of Medicinal Chemistry
|
February 12, 2010
Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's disease
Balaram Ghosh, Tamara Antonio, Maarten E A Reith, et al.
International Immunopharmacology
|
October 19, 2025
HDAC6 inhibition attenuates RIPK1/RIPK3/MLKL signalling and improves anti-tumor immune response in oral cancer
Ashutosh Mahale, Sanjeev Regula, Bhavesha Chanchlani, et al.
International Journal of Biological Macromolecules
|
March 3, 2024
Cationized gelatin-sodium alginate polyelectrolyte nanoparticles encapsulating moxifloxacin as an eye drop to treat bacterial keratitis
Sanjay Ch, Milan Paul, Sri Ganga Padaga, et al.
Heliyon
|
December 10, 2024
Exploring the key structural attributes and chemico-biological interactions of pyridinone-based SARS-CoV-2 3CL<sup>pro</sup> inhibitors through validated structure-based drug design strategies
Suvankar Banerjee, Sandip Kumar Baidya, Balaram Ghosh, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 2, 2018
Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects
Prakruti Trivedi, Nilanjan Adhikari, Sk Abdul Amin, et al.
European Journal of Medicinal Chemistry
|
September 5, 2018
HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches
Nilanjan Adhikari, Sk Abdul Amin, Prakruti Trivedi, et al.
European Journal of Pharmacology
|
June 20, 2008
D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like action
Aloke K Dutta, Balaram Ghosh, Swati Biswas, et al.
The Journal of Allergy and Clinical Immunology
|
July 8, 2008
Genetic association of acidic mammalian chitinase with atopic asthma and serum total IgE levels
Rajshekhar Chatterjee, Jyotsna Batra, Sudipta Das, et al.
European Journal of Medicinal Chemistry
|
February 9, 2019
Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides
Sk Abdul Amin, Nilanjan Adhikari, Sonali Kotagiri, et al.
Page
of 29
Search research articles
Search
Showing results (91-100 of 281) with videos related to
Sort By:
Page
of 29
Journal of Molecular Structure
|
December 5, 2022
Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences
Suvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, et al.
Journal of Medicinal Chemistry
|
February 12, 2010
Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's disease
Balaram Ghosh, Tamara Antonio, Maarten E A Reith, et al.
International Immunopharmacology
|
October 19, 2025
HDAC6 inhibition attenuates RIPK1/RIPK3/MLKL signalling and improves anti-tumor immune response in oral cancer
Ashutosh Mahale, Sanjeev Regula, Bhavesha Chanchlani, et al.
International Journal of Biological Macromolecules
|
March 3, 2024
Cationized gelatin-sodium alginate polyelectrolyte nanoparticles encapsulating moxifloxacin as an eye drop to treat bacterial keratitis
Sanjay Ch, Milan Paul, Sri Ganga Padaga, et al.
Heliyon
|
December 10, 2024
Exploring the key structural attributes and chemico-biological interactions of pyridinone-based SARS-CoV-2 3CL<sup>pro</sup> inhibitors through validated structure-based drug design strategies
Suvankar Banerjee, Sandip Kumar Baidya, Balaram Ghosh, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 2, 2018
Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects
Prakruti Trivedi, Nilanjan Adhikari, Sk Abdul Amin, et al.
European Journal of Medicinal Chemistry
|
September 5, 2018
HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches
Nilanjan Adhikari, Sk Abdul Amin, Prakruti Trivedi, et al.
European Journal of Pharmacology
|
June 20, 2008
D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like action
Aloke K Dutta, Balaram Ghosh, Swati Biswas, et al.
The Journal of Allergy and Clinical Immunology
|
July 8, 2008
Genetic association of acidic mammalian chitinase with atopic asthma and serum total IgE levels
Rajshekhar Chatterjee, Jyotsna Batra, Sudipta Das, et al.
European Journal of Medicinal Chemistry
|
February 9, 2019
Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides
Sk Abdul Amin, Nilanjan Adhikari, Sonali Kotagiri, et al.
Page
of 29